Table 4.
Variables | Model 1 | Model 2 | Model 3 | Model 4 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | p | Odds ratio | 95% CI | p | Odds ratio | 95% CI | p | Odds ratio | 95% CI | p | |
Age (years) | 1.06 | 1.04–1.08 | < 0.001 | 1.06 | 1.04–1.08 | < 0.001 | 1.06 | 1.04–1.09 | < 0.001 | 1.06 | 1.04–1.09 | < 0.001 |
Hypertension | 1.04 | 0.53–2.02 | 0.912 | 1.18 | 0.6–2.32 | 0.629 | 1.04 | 0.51–2.1 | 0.922 | 0.96 | 0.47–1.97 | 0.915 |
Chronic kidney disease | 2.73 | 1.57–4.77 | < 0.001 | 2.96 | 1.67–5.25 | < 0.001 | 2.96 | 1.62–5.4 | < 0.001 | 2.97 | 1.63–5.44 | < 0.001 |
Currently active malignancy | 2.28 | 1.24–4.2 | 0.008 | 2.62 | 1.39–4.92 | 0.003 | 2.59 | 1.33–5.03 | 0.005 | 2.64 | 1.35–5.13 | 0.004 |
Past history of malignancy | 0.76 | 0.27–2.12 | 0.595 | 0.72 | 0.25–2.08 | 0.545 | 0.62 | 0.2–1.88 | 0.393 | 0.63 | 0.21–1.92 | 0.416 |
Vaccination status | 0.057 | 0.027 | 0.024 | |||||||||
Linear | 0.51 | 0.29–0.89 | 0.017 | 0.45 | 0.25–0.81 | 0.007 | 0.44 | 0.24–0.79 | 0.006 | |||
Deviation | 0.89 | 0.58–1.37 | 0.589 | 0.83 | 0.52–1.3 | 0.412 | 0.84 | 0.53–1.32 | 0.441 | |||
Lymphocytes (%) | 0.97 | 0.94–1 | 0.036 | 0.97 | 0.94–1 | 0.042 | ||||||
C-reactive protein (mg/l) | 1.01 | 1–1.01 | < 0.001 | 1.01 | 1–1.01 | < 0.001 | ||||||
Atrial fibrillation | 1.86 | 0.93–3.71 | 0.078 |
95% CI, 95% confidence interval
Model 1, independent predictors of vaccination (age, hypertension, chronic kidney disease, currently active malignancy, past history of malignancy; method: enter)
Model 2, model 1 + vaccination status (no or partial — 0, full primary — 1, booster — 2; method: enter, contrast: polynomial)
Model 3, model 2 + laboratory measures (white blood cell count, neutrophils, lymphocytes, procalcitonin, C-reactive protein, serum creatinine, serum albumin; method: backward stepwise)
Model 4, model 3 + medical history (diabetes mellitus, hyperlipidaemia, myocardial infarction/heart failure, stroke, atrial fibrillation, dementia; method: backward stepwise)